Carl Regillo, MD, FASRS, is the Director of the Retina Service Unit of Wills Eye Hospital in Philadelphia, Professor of Ophthalmology at Thomas Jefferson University School of Medicine, as well as founder and former Director of the Wills Eye Clinical Retina Research Unit. As the principal Investigator of numerous international clinical trials, he investigates new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions. He was prior Chairman of the Wills Eye Institutional Review Board, prior Chairman of the American Academy’s Basic and Clinical Science Course (BCSC) Retina Section Committee, as well as the former Wills Retina Fellowship Program Director.
Dr. Regillo is a Phi Kappa Phi graduate of Northeastern University, College of Pharmacy, where he was the class Valedictorian. He received his medical degree from Harvard Medical School on a full military scholarship. He performed his internship in internal medicine at Harvard’s Brigham and Women’s Hospital in Boston, and both his ophthalmology residency and vitreoretinal fellowship at Wills Eye Hospital. He was appointed Co-Chief Resident and awarded a Heed Ophthalmic Fellowship during his postgraduate training.
After training, he was commissioned a Major in the United States Air Force and stationed four years as a vitreoretinal surgeon at the San Diego Naval Medical Center, where he was Co-Director of the Ophthalmology Department’s Retina Service, Assistant Professor of Ophthalmology at the University of California, San Diego, and recipient of a Naval Commendation medal and the Ophthalmology Department’s annual teaching award. In 1998, he returned to Philadelphia to join Mid Atlantic Retina and the Retina Service of Wills Eye Hospital.
Dr. Regillo has authored over 300 scientific papers, lectured nationally and abroad, and has published nine major textbooks in the field. He has served on the scientific editorial board for the American Journal of Ophthalmology, Review of Ophthalmology, Current Opinion in Ophthalmology, Yearbook of Ophthalmology, Retinal Physician, and Retina Today. He is a fellow of the American College of Surgeons and an active member of the American Academy of Ophthalmology, The Retina Society, The Macula Society, and The American Society of Retina Specialists. He is a former examiner for the American Board of Ophthalmology and a recipient of the American Academy of Ophthalmology Achievement, Senior Achievement, Secretariat, and Lifetime Achievement Awards along with the America Society of Retina Specialists Honor, Senior Honor, Presidential and Founders Awards. In 2018, he received the Wills Eye Silver Tray Award, the Hospital’s highest honor. He was named one of the “150 Top Innovators in Retina” by Ocular Surgery News, selected a Charter Inductee of the Retina Hall of Fame in 2017, and on the Ophthalmology Power List of the top 100 most influential people in the world of ophthalmology. He has been listed annually for over two decades as a retina “Top Doctor” in the Philadelphia Magazine, Philadelphia Life, Mainline Today and South Jersey Magazine, andwas named among the top 150 ophthalmologists in the US by Newsweek.